IL33 and COVID-19: The aim of this study was to determine the association of Gal-1 and innate immunity cytokines such as IL-1β, IL-6, IL-10, IL-23, IL-33 with disease severity, alongside with clinical, biochemical features and Chest X-rays (CXR) lung findings in 210 patients with COVID-19.